Drawing for RHEUMAGEN

USPTO serial 90372395

RHEUMAGEN

Reviewed by CopyMark Law Group

Reg. 8096117Status 700Registered
Filing date
Status date
Registration date
Jan 6, 2026
Examiner
PERRY,KIMBERLY B
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with RHEUMAGEN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jenny T. Slocum

Jenny T. Slocum Dickinson Wright, PLLC1825 Eye Street N.W.; Suite 900WASHINGTON, DC 20006United States

Goods and services

ClassDescriptionStatusFirst use
042Product development for others in the field of pharmaceutical preparations and therapeutic treatments, including for gene therapy and gene editing; scientific consulting and research services relating to pharmaceuticals and therapeutic treatments; research and development of new products, including for gene therapy and gene editing; Providing medical and scientific research information in the fields of pharmaceuticals, biochemistry, biotechnology, and clinical trials; drug discovery services; Providing medical research information in the fields of diagnostic, prophylactic, and therapeutic properties of pharmaceuticalsACTIVEMay 6, 2020
044Providing medical information in the fields of diagnostic, prophylactic, and therapeutic properties of pharmaceuticals; online medical information servicesACTIVEMay 6, 2020

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 6, 2026NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 6, 2026R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 12, 2025SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Dec 12, 2025CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Dec 11, 2025DOCKASSIGNED TO EXAMINER
Dec 11, 2025DOCKASSIGNED TO EXAMINER
Feb 28, 2025SUPCSTATEMENT OF USE PROCESSING COMPLETE
Feb 21, 2025IUAFUSE AMENDMENT FILED
Feb 21, 2025EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Aug 13, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 13, 2024EX5GSOU EXTENSION 5 GRANTED
Aug 13, 2024EXT5SOU EXTENSION 5 FILED
Aug 13, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 21, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 20, 2024EX4GSOU EXTENSION 4 GRANTED
Feb 20, 2024EXT4SOU EXTENSION 4 FILED
Feb 20, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 3, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 2, 2023EX3GSOU EXTENSION 3 GRANTED
Oct 2, 2023AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL
Sep 5, 2023NREVNOTICE OF REVIVAL - E-MAILED
Sep 5, 2023TPEXSOU EXTENSION RECEIVED WITH TEAS PETITION
Sep 5, 2023NREVNOTICE OF REVIVAL - E-MAILED
Sep 5, 2023DOCKASSIGNED TO EXAMINER
Sep 5, 2023PETGPETITION TO REVIVE-GRANTED
Sep 5, 2023PROATEAS PETITION TO REVIVE RECEIVED
Aug 22, 2023EXT3SOU EXTENSION 3 FILED
Feb 22, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 20, 2023EX2GSOU EXTENSION 2 GRANTED
Feb 20, 2023EXT2SOU EXTENSION 2 FILED
Feb 20, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 1, 2023ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Aug 24, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 22, 2022EX1GSOU EXTENSION 1 GRANTED
Aug 22, 2022EXT1SOU EXTENSION 1 FILED
Aug 22, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 12, 2022DOCKASSIGNED TO EXAMINER
Feb 22, 2022NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Dec 28, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 28, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 8, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 22, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Nov 20, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Nov 20, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 20, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 9, 2021GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 9, 2021GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 9, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 2, 2021DOCKASSIGNED TO EXAMINER
Feb 17, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 14, 2020NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance